Mechanical Thrombectomy Devices Market Size, Share and Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2024 – 2032

Mechanical Thrombectomy Devices Market 

Mechanical Thrombectomy Devices Market size is anticipated to witness significant growth from 2024 to 2032 on account of the expanding geriatric population and rise in the rate of cardiovascular diseases worldwide. As per WHO, cardiovascular diseases stand as the primary cause of death, claiming approximately 17.9 million lives annually. Various factors like hectic schedules, physical inactivity, and unhealthy diet, along with harmful intake of alcohol and use of tobacco, cause CVDs.
 

The rise in the use of clot retrievers and stents to treat strokes and a surge in number of vascular diseases propels the use of thrombectomy in surgical centers and hospitals. Additionally, the rising investment in R&D activities to bring in top-notch thrombectomy devices by manufacturers.
 

Mechanical Thrombectomy Devices Market Trends

One notable trend is the increasing adoption of minimally invasive procedures for the treatment of vascular diseases, including strokes caused by blood clots. The advancements in mechanical thrombectomy technology are leading to improved efficacy and safety of procedures. Additionally, there is a growing emphasis on reducing treatment times and improving patient outcomes, prompting healthcare providers to integrate mechanical thrombectomy devices into their standard protocols for acute stroke management. This is will further shape the industry outlook in the coming years.
 

Mechanical Thrombectomy Devices Market Analysis

The automated device segment share is poised to increase significantly by 2032 owing to the proliferation of automation technology in the healthcare sector. Automated thrombectomy devices use various control systems to remove blood vessel clots automatically, including thrombectomy tools operated consecutively under computer control. The cognizance pertaining to the various benefits of automated devices.
 

Based on end-user, hospitals segment is slated to register notable growth through 2032 backed by the treatment of acute ischemic stroke patients with large artery diseases using stent retrievers in these settings. With the technological developments in minimally invasive surgeries, the use of new thrombectomy devices, endovascular thrombectomy with catheters, stent retrievers, and interventional therapy have emerged as the standard treatment for chronic diseases. The rise of non-invasive treatment technology, allowing patients to receive treatment within 24 hours in specific cases, alongside the growing number of hospitals worldwide.
 

North America mechanical thrombectomy devices market will observe considerable expansion over 2024 and 2032 owing to the ongoing technological advancements, increase in the geriatric population, and rising number of patients suffering from neurological and cardiovascular diseases in the region. According to the National Institute of Health, heart ailments like strokes are the most common reason for fatalities in the United States. The increase in the adoption of mechanical thrombectomy treatments as well as medical reimbursement services from central governments leading to cost-effective procedure will augment the regional industry expansion.
 

Mechanical Thrombectomy Devices Market Share

The prominent players operating in the mechanical thrombectomy devices industry are:

• Edward Lifesciences Corporation
• Stryker Corporation
• Boston Scientific
• Johnson & Johnson
• Argon Medical Devices Inc.
   

Mechanical Thrombectomy Devices Industry News

• In February 2024, Edwards Lifesciences Corporation announced that company's EVOQUE tricuspid valve replacement system became the first transcatheter therapy to receive U.S. FDA approval for treating tricuspid regurgitation.